The improvement of symptoms alone is no longer a satisfactory outcome for patients with Crohn's disease. The authors of this Viewpoint article argue that modification of the clinical course of Crohn's disease should be the major goal of medical therapy. Preliminary data suggest that the early use of biologics could achieve this aim in a subset of patients.
- Sandro Ardizzone
- Gabriele Bianchi Porro
